These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 3117563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
    James CA, Mant TG, Rogers HJ.
    Br J Clin Pharmacol; 1987 May; 23(5):561-8. PubMed ID: 3109461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
    el-Yazigi A, Ernst P, al-Rawithi S, Legayada E, Raines DA.
    J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
    [Abstract] [Full Text] [Related]

  • 8. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N, Pohl J.
    IARC Sci Publ; 1986 Jul; (78):269-79. PubMed ID: 3108156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP, Houle JM, Bush DA, Li JT, Newman CE, Brade WP.
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
    Ormstad K, Uehara N.
    FEBS Lett; 1982 Dec 27; 150(2):354-8. PubMed ID: 6819161
    [Abstract] [Full Text] [Related]

  • 13. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
    Ormstad K, Ohno Y.
    Cancer Res; 1984 Sep 27; 44(9):3797-800. PubMed ID: 6430554
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of orally administered mesna.
    Burkert H, Lücker PW, Wetzelsberger N, Breuel HP.
    Arzneimittelforschung; 1984 Sep 27; 34(11):1597-600. PubMed ID: 6441581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
    Reuther H, Kohl M, Wildenauer DB.
    Arzneimittelforschung; 1986 Apr 27; 36(4):763-5. PubMed ID: 3087373
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N, Stekar J.
    Arzneimittelforschung; 1982 Apr 27; 32(5):486-7. PubMed ID: 6809014
    [Abstract] [Full Text] [Related]

  • 18. Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
    Cutler MJ, Velenosi TJ, Bodalia A, House AA, Urquhart BL, Freeman DJ.
    Amino Acids; 2015 Mar 27; 47(3):511-23. PubMed ID: 25488427
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP, Epelman S, Bush DA.
    Cancer Chemother Pharmacol; 2004 Sep 27; 54(3):237-40. PubMed ID: 15184993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.